Diagnosis, treatment and full-process surveillance of early rectal cancer
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 3
Abstract
Early rectal cancer is defined as any size of rectal epithelial tumor with infiltration depth limited to the mucosa and submucosa, regardless of with or without lymph node metastasis. Local resection is one of the main treatment methods for early rectal cancer without local lymph node metastasis. The development of endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), transanal endoscopic microsurgery (TEM), and transanal minimally invasive surgery (TAMIS) has brought more options for the treatment of early rectal cancer. About 8%-12% of early rectal cancer patients have local lymph node metastasis and therefore still require total mesorectal excision (TME). The current guidelines recommend that early rectal cancer with high-risk pathological features requires additional salvage radical surgery. Various minimally invasive and anal sphincter-preserving surgical techniques, such as natural orifice specimen extraction surgery (NOSES), transanal total mesorectal excision (TaTME), intersphincteric resection (ISR), and conformal sphincter-preserving operation (CSPO), have better achieved the goal of anal sphincter preservation and anal function preservation. The overall prognosis of early rectal cancer is good, but full-process surveillance is equally important. With the innovation of early diagnosis, early treatment and full-process surveillance, the development of endoscopic and surgical techniques will further improve the standardization of diagnosis and treatment for early rectal cancer.
Authors and Affiliations
Ping LAN, Yongle CHEN, Xiaosheng HE
Keywords
Related Articles
- EP ID EP750964
- DOI 10.16139/j.1007-9610.2024.03.03
- Views 5
- Downloads 0
Effect of hyperlipidemia on prognosis of the patients with hepatitis B related hepatocellular carcinoma
[Objective] To explore the effect of hyperlipidemia and lipid-lowering therapy on the prognosis of postoperative patients with hepatitis B related hepatocellular carcinoma. [Methods] The clinical data of the patients wit...
Current status and development of laparoscopic hepatectomy
Combination of targeted multikinase inhibitor and radioiodine: a new strategy of treatment for advanced differentiated thyroid carcinoma
Advanced differentiated thyroid carcinoma (ADTC) lacks effective treatment options, and has a poor prognosis, which is an urgent clinical problem to be resolved. Targeted multikinase inhibitor(MKI) has been approved for...
Nutritional therapy recommendations for patients with coronavirus disease 2019 (COVID-19) in Ruijin Hospital (2023 edition)
Nutritional support is one of the comprehensive treatments for the patients with novel coronavirus infection, especially for critically ill patients. Nutritional therapy needs to follow the standard process, which includ...
<![CDATA[Precision surgery in diagnosis and treatment of hepatocellular carcinoma]]>
<![CDATA[]]>